European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision
| العنوان: | European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision |
|---|---|
| المؤلفون: | Pieter A. van Doorn, Patricia H. Blomkwist-Markens, Michael P. Lunn, Filip Eftimov, Haluk Topaloglu, H. Stephan Goedee, Luis Querol, Claudia Sommer, Shahram Attarian, Bert Avau, Patrik Vankrunkelsven, Thomas Harbo, Yusuf A. Rajabally, Peter Van den Bergh, Jeffrey A. Allen, Satoshi Kuwabara, David R. Cornblath, Eduardo Nobile-Orazio, Richard A. Lewis, Robert D M Hadden |
| المساهمون: | UCL - SSS/IONS - Institute of NeuroScience, UCL - (SLuc) Service de neurologie, UCL - (SLuc) Centre de référence neuromusculaire, Neurology, AII - Inflammatory diseases, ANS - Neuroinfection & -inflammation, EURO-NMD |
| المصدر: | European journal of neurology, Vol. 28, no.11, p. 3556-3583 (2021) Journal of the peripheral nervous system, Vol. 26, no.3, p. 242-268 (2021) Van den Bergh, P Y K, van Doorn, P A, Hadden, R D M, Avau, B, Vankrunkelsven, P, Allen, J A, Attarian, S, Blomkwist-Markens, P H, Cornblath, D R, Eftimov, F, Goedee, H S, Harbo, T, Kuwabara, S, Lewis, R A, Lunn, M P, Nobile-Orazio, E, Querol, L, Rajabally, Y A, Sommer, C & Topaloglu, H A 2021, ' European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy : Report of a joint Task Force—Second revision ', Journal of the Peripheral Nervous System, vol. 26, no. 3, pp. 242-268 . https://doi.org/10.1111/jns.12455Test Van den Bergh, P Y K, van Doorn, P A, Hadden, R D M, Avau, B, Vankrunkelsven, P, Allen, J A, Attarian, S, Blomkwist-Markens, P H, Cornblath, D R, Eftimov, F, Goedee, H S, Harbo, T, Kuwabara, S, Lewis, R A, Lunn, M P, Nobile-Orazio, E, Querol, L, Rajabally, Y A, Sommer, C & Topaloglu, H A 2021, ' European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy : Report of a joint Task Force—Second revision ', European Journal of Neurology, vol. 28, no. 11, pp. 3556-3583 . https://doi.org/10.1111/ene.14959Test European journal of neurology, 28(11), 3556-3583. Wiley-Blackwell JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Journal of the Peripheral Nervous System, 26(3), 242-268. Wiley-Blackwell Publishing Ltd EUROPEAN JOURNAL OF NEUROLOGY Journal of the peripheral nervous system, 26(3), 242-268. Wiley-Blackwell European Journal of Neurology, 28(11), 3556-3583. Wiley-Blackwell Publishing Ltd |
| بيانات النشر: | Wiley, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, Pediatrics, Neurology, diagnosis, Population, Disease, CIDP, Peripheral nerve, Adrenal Cortex Hormones, medicine, Humans, Peripheral Nerves, education, education.field_of_study, Plasma Exchange, treatment, Maintenance dose, business.industry, General Neuroscience, Immunoglobulins, Intravenous, Polyradiculoneuropathy, Guideline, medicine.disease, GRADE, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Neuropathic pain, Neurology (clinical), business, guideline |
| الوصف: | Objective: To revise the 2010 consensus guideline on chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods: Seventeen disease experts, a patient representative, and two Cochrane methodologists constructed 12 Population/Intervention/Comparison/Outcome (PICO) questions regarding diagnosis and treatment to guide the literature search. Data were extracted and summarized in GRADE summary of findings (for treatment PICOs) or evidence tables (for diagnostic PICOs). Results: Statements were prepared according to the GRADE Evidence-to-Decision frameworks. Typical CIDP and CIDP variants were distinguished. The previous term “atypical CIDP” was replaced by “CIDP variants” because these are well characterized entities (multifocal, focal, distal, motor, or sensory CIDP). The levels of diagnostic certainty were reduced from three (definite, probable, possible CIDP) to only two (CIDP and possible CIDP), because the diagnostic accuracy of criteria for probable and definite CIDP did not significantly differ. Good Practice Points were formulated for supportive criteria and investigations to be considered to diagnose CIDP. The principal treatment recommendations were: (a) intravenous immunoglobulin (IVIg) or corticosteroids are strongly recommended as initial treatment in typical CIDP and CIDP variants; (b) plasma exchange is strongly recommended if IVIg and corticosteroids are ineffective; (c) IVIg should be considered as first-line treatment in motor CIDP (Good Practice Point); (d) for maintenance treatment, IVIg, subcutaneous immunoglobulin or corticosteroids are recommended; (e) if the maintenance dose of any of these is high, consider either combination treatments or adding an immunosuppressant or immunomodulatory drug (Good Practice Point); and (f) if pain is present, consider drugs against neuropathic pain and multidisciplinary management (Good Practice Point). |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 1351-5101 1085-9489 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac7b3a05ac0fa19b7a372fc0e1e85c8Test https://hdl.handle.net/2078.1/264369Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....4ac7b3a05ac0fa19b7a372fc0e1e85c8 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 13515101 10859489 |
|---|